CytoMed Therapeutics Ltd
GDTC1.860USD
+0.030+1.64%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.845USD+1.845After-hours 08/04, 20:00 (ET)
21.44MMarket Cap
--P/E TTM
CytoMed Therapeutics Ltd
1.860
+0.030+1.64%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
Total revenue
--69.50K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Revenue
--69.50K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating expenses
-50.93%958.85K
-22.09%1.65M
78.07%1.95M
177.12%2.11M
12.45%1.10M
0.35%762.40K
24.49%975.81K
54.40%759.76K
--783.87K
--492.07K
R&D expenses
29.29%842.87K
29.21%853.68K
-15.48%651.92K
40.46%660.67K
69.98%771.28K
15.22%470.36K
-31.79%453.75K
9.47%408.23K
--665.17K
--372.92K
Depreciation, depletion, and amortization
-5.37%168.49K
-17.83%166.87K
-13.94%178.06K
6.34%203.09K
18.90%206.91K
14.72%190.98K
14.09%174.02K
18.90%166.47K
--152.53K
--140.01K
Other operating expenses
-747.87%-796.72K
-21.21%-225.68K
69.79%-93.97K
-32.70%-186.18K
-287.09%-311.05K
-275.24%-140.30K
-5.33%-80.36K
-90.04%-37.39K
---76.29K
---19.67K
Operating profit
54.48%-889.35K
22.09%-1.65M
-78.07%-1.95M
-177.12%-2.11M
-12.45%-1.10M
-0.35%-762.40K
-24.49%-975.81K
-54.40%-759.76K
---783.87K
---492.07K
Net non-operating interest income (expenses)
Non-operating interest income
-49.76%127.13K
483.26%190.54K
40130.68%253.05K
2123.83%32.67K
-81.34%629.00
--1.47K
--3.37K
----
----
----
Non-operating interest expense
-0.15%10.51K
-75.94%9.80K
-83.33%10.52K
-34.31%40.76K
5.17%63.13K
7.59%62.04K
-7.41%60.03K
41.74%57.67K
--64.83K
--40.69K
Gains from sale of securities
-47.10%-369.89K
159.57%210.63K
-1418.92%-251.46K
922.31%81.15K
-598.19%-16.55K
22.93%-9.87K
-39.29%3.32K
-116.76%-12.80K
--5.47K
---5.91K
Return on equity
80.99%-2.17K
180.68%15.94K
-1.58%-11.44K
11.34%-19.76K
94.70%-11.26K
---22.28K
---212.58K
----
----
----
Special income (expenses)
---288.53K
252.13%150.24K
100.00%0.00
29.88%-98.75K
-539.80%-946.54K
27.84%-140.84K
138.21%215.22K
-2162.25%-195.17K
---563.20K
--9.46K
- Gains from disposal of fixed assets
----
----
----
----
---290.00
--570.00
----
----
----
----
Income before tax
27.40%-1.43M
49.56%-1.09M
7.50%-1.97M
-116.82%-2.16M
-107.93%-2.13M
2.93%-995.39K
27.01%-1.03M
-93.76%-1.03M
---1.41M
---529.20K
Income tax
----
--0.00
-60.18%653.00
----
--1.64K
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
27.42%-1.43M
49.56%-1.09M
7.54%-1.97M
-116.82%-2.16M
-108.09%-2.14M
2.93%-995.39K
27.01%-1.03M
-93.76%-1.03M
---1.41M
---529.20K
Net income from continuous operations
27.42%-1.43M
49.56%-1.09M
7.54%-1.97M
-116.82%-2.16M
-108.09%-2.14M
2.93%-995.39K
27.01%-1.03M
-93.76%-1.03M
---1.41M
---529.20K
Net Income attributable to non-controlling interests
-3644.78%-5.02K
-3.57%-145.00
3.60%-134.00
-34.62%-140.00
-11.20%-139.00
18.75%-104.00
32.80%-125.00
---128.00
---186.00
--0.00
Net income attributable to controlling interests
27.67%-1.43M
49.57%-1.09M
7.54%-1.97M
-116.83%-2.16M
-108.10%-2.14M
2.92%-995.29K
27.01%-1.03M
-93.74%-1.03M
---1.41M
---529.20K
Net income attributable to common shareholders
27.67%-1.43M
49.57%-1.09M
7.54%-1.97M
-116.83%-2.16M
-108.10%-2.14M
2.92%-995.29K
27.01%-1.03M
-93.74%-1.03M
---1.41M
---529.20K
Basic earnings per share
27.67%-0.12
57.52%-0.09
60.82%-0.17
-144.03%-0.22
-388.05%-0.44
2.92%-0.09
30.38%-0.09
-93.76%-0.09
---0.13
---0.05
Diluted earnings per share
27.67%-0.12
57.52%-0.09
60.82%-0.17
-144.03%-0.22
-388.05%-0.44
2.92%-0.09
30.38%-0.09
-93.76%-0.09
---0.13
---0.05
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
